Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 0: 200302920, 2004; 10.1373/clinchem.2003.029207
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2003.029207v1
50/3/589    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hattori, H.
Right arrow Articles by Miller, N. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hattori, H.
Right arrow Articles by Miller, N. E.

Received on November 12, 2003
Accepted on December 30, 2003

Lipids, Lipoproteins, and Cardiovascular Risk Factors

Association of Coronary Heart Disease with Pre-{beta}-HDL Concentrations in Japanese Men

Hiroaki Hattori 1, Takeshi Kujiraoka 1, Tohru Egashira 1, Eiji Saito 2, Takayuki Fujioka 2, Sadao Takahashi 3, Mayumi Ito 1, Jackie A. Cooper 4, Irina P. Stepanova 5, M. Nazeem Nanjee 5*, Norman E. Miller 6

1 Research Department, R & D Center, BML, Kawagoe, Saitama, Japan
2 Second Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan
3 Third Department of Internal Medicine, Fukui Medical University, Fukui, Japan
4 MRC Epidemiology and Medical Care Unit, Wolfson Institute of Preventive Medicine, London, UK
5 Cardiovascular Biochemistry Unit, St. Bartholomew’s and the Royal London School of Medicine and Dentistry, London, UK
6 Cardiovascular Biochemistry Unit, St. Bartholomew’s and the Royal London School of Medicine and Dentistry, London, UK, and Current address: Molecular Pathology Laboratory, International Centre for Genetic Engineering and Biotechnology, Trieste, Italy

* To whom correspondence should be addressed. E-mail: nazeem{at}ucvg.med.utah.edu.

Background: In individuals heterozygous for ABCA1 transporter mutations, defective reverse cholesterol transport (RCT) causes low HDL-cholesterol and premature coronary heart disease (CHD). However, the extent to which impaired RCT underlies premature CHD in others with low HDL-cholesterol is not known. The primary acceptors of cell cholesterol are a minor subclass of lipid-poor pre-{beta}-HDLs. These are generated during remodeling of {alpha}-HDLs, which account for almost all HDL-cholesterol. We studied the strength of the association of CHD with pre-{beta}-HDL concentrations in Japanese men.

Methods: Blood was collected from 42 men with clinical CHD and 44 healthy controls 40-70 years of age. Pre-{beta}-HDL was assayed by crossed immunoelectrophoresis.

Results: Cases had lower HDL-cholesterol (-23%), total apolipoprotein A-I (-26%), and pre-{beta}-HDL (-55%; all P <0.001) concentrations; lower pre-{beta}-HDL:{alpha}-HDL ratios (-45%; P <0.001); and higher plasma triglycerides (20%; P <0.03) than the controls. On stepwise logistic regression, CHD was associated most strongly with pre-{beta}-HDL concentrations. On ROC analysis, pre-{beta}-HDL concentration discriminated between cases and controls better than any other lipoprotein measurement. When plasma was incubated for 16 h at 37 °C, mean (SD) pre-{beta}-HDL increased by 47 (5)% in controls, but was unchanged in cases (group difference, P <0.001).

Conclusions: Our results suggest that inefficient RCT, secondary to a low pre-{beta}-HDL concentration and production rate in plasma, contributes to premature CHD in Japanese men with low HDL-cholesterol.




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
M. Suzuki, H. Wada, S. Maeda, K. Saito, S. Minatoguchi, K. Saito, and M. Seishima
Increased Plasma Lipid-Poor Apolipoprotein A-I in Patients with Coronary Artery Disease
Clin. Chem., January 1, 2005; 51(1): 132 - 137.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2004 by the American Association for Clinical Chemistry.